NCT03896139
- Conditions
- Kinase Inhibitors Toxicity
- Locations
-
- AP-HP, Pitié-Salpêtrière Hospital, Department of Pharmacology, CIC-1421, Pharmacovigilance Unit, INSERM Paris, France
Clinical trial condition
Explore clinical trials studying Kinase Inhibitors Toxicity. Study availability and eligibility vary by location and protocol.
NCT03896139